CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6.

Yoshiba, Takahiro; Saga, Yasushi; Urabe, Masashi; Uchibori, Ryosuke; Matsubara, Shigeki; Fujiwara, Hiroyuki; Mizukami, Hiroaki.

Afiliação

Yoshiba T; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Saga Y; Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Urabe M; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Uchibori R; Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Matsubara S; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Fujiwara H; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.
Mizukami H; Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan.

Oncol Lett ; 17(2): 2197-2206, 2019 Feb.

Article em En | MEDLINE | ID: mdl-30675284

Palavras-chave

E6; adeno-associated virus vector; cervical cancer; clustered regularly interspaced short palindromic repeats-CRISPR associated proteins 9; high-risk human papilloma virus

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article